BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27033734)

  • 1. Synthesis and biological evaluation of novel 2-phenylquinazoline-4-amine derivatives: identification of 6-phenyl-8H-benzo[g]quinazolino[4,3-b]quinazolin-8-one as a highly potent inducer of NAD(P)H quinone oxidoreductase 1.
    Ghorab MM; Alsaid MS; El-Gazzar MG; Higgins M; Dinkova-Kostova AT; Shahat AA
    J Enzyme Inhib Med Chem; 2016; 31(sup1):34-39. PubMed ID: 27033734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 4-aminoquinazoline derivatives.
    Ghorab MM; Alsaid MS; El-Gazzar MG; Higgins M; Dinkova-Kostova AT; Shahat AA
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1369-74. PubMed ID: 26796666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivatives.
    Ghorab MM; Alsaid MS; Higgins M; Dinkova-Kostova AT; Shahat AA; Elghazawy NH; Arafa RK
    Drug Des Devel Ther; 2016; 10():2515-24. PubMed ID: 27540279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives.
    Ghorab MM; Alsaid MS; Higgins M; Dinkova-Kostova AT; Shahat AA; Elghazawy NH; Arafa RK
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1612-8. PubMed ID: 27052554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinazolin-4(3H)-ones carrying a sulfonamide moiety.
    Soliman AM; Karam HM; Mekkawy MH; Higgins M; Dinkova-Kostova AT; Ghorab MM
    Eur J Med Chem; 2020 Aug; 200():112467. PubMed ID: 32502866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel iodinated quinazolinones bearing sulfonamide as new scaffold targeting radiation induced oxidative stress.
    Soliman AM; Mekkawy MH; Karam HM; Higgins M; Dinkova-Kostova AT; Ghorab MM
    Bioorg Med Chem Lett; 2021 Jun; 42():128002. PubMed ID: 33811990
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Vaghefinezhad N; Farsani SF; Gharaghani S
    Curr Drug Discov Technol; 2021; 18(1):139-157. PubMed ID: 31721705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and molecular docking studies of novel quinazolinones as antitubercular and antimicrobial agents.
    Kumar Pandey S; Yadava U; Upadhyay A; Sharma ML
    Bioorg Chem; 2021 Mar; 108():104611. PubMed ID: 33484939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel quinazolin-4(3H)-ones as inhibitors of thermolysin, the prototype of the M4 family of proteinases.
    Khan MT; Khan R; Wuxiuer Y; Arfan M; Ahmed M; Sylte I
    Bioorg Med Chem; 2010 Jun; 18(12):4317-27. PubMed ID: 20494587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkynyloxy derivatives of 5,8-quinolinedione: Synthesis, in vitro cytotoxicity studies and computational molecular modeling with NAD(P)H:Quinone oxidoreductase 1.
    Kadela-Tomanek M; Jastrzębska M; Pawełczak B; Bębenek E; Chrobak E; Latocha M; Książek M; Kusz J; Boryczka S
    Eur J Med Chem; 2017 Jan; 126():969-982. PubMed ID: 28006669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
    Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
    Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors.
    Elfeky SM; Sobahi TR; Gineinah MM; Ahmed NS
    Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900211. PubMed ID: 31696968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron affinity of tricyclic, bicyclic, and monocyclic compounds containing cyanoenones correlates with their potency as inducers of a cytoprotective enzyme.
    Bensasson RV; Dinkova-Kostova AT; Zheng S; Saito A; Li W; Zoete V; Honda T
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4345-9. PubMed ID: 27460172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Anti-Proliferative Evaluations of New Heterocyclic Derivatives Using 5,6,8,9-Tetrahydropyrazolo[5,1-b]quinazolin-7(3H)-one Derivatives Derived from Cyclohexa-1,4-dione.
    Mahmoud MAA; Alsharif MA; Mohareb RM
    Anticancer Agents Med Chem; 2021; 21(4):468-486. PubMed ID: 32445457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, Antimicrobial and Anti-biofilm Evaluation, and Molecular Docking of Newly Substituted Fluoroquinazolinones.
    Zayed MF; Ibrahim SRM; Habib EE; Hassan MH; Ahmed S; Rateb HS
    Med Chem; 2019; 15(6):659-675. PubMed ID: 30411687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
    Huang WY; Zhang XR; Lyu L; Wang SQ; Zhang XT
    Bioorg Chem; 2020 Jun; 99():103814. PubMed ID: 32278208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.
    Ling Y; Yang QX; Teng YN; Chen S; Gao WJ; Guo J; Hsu PL; Liu Y; Morris-Natschke SL; Hung CC; Lee KH
    Eur J Med Chem; 2018 Jun; 154():199-209. PubMed ID: 29803003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: An update on the development of synthetic methods and pharmacological diversification.
    Khan I; Zaib S; Batool S; Abbas N; Ashraf Z; Iqbal J; Saeed A
    Bioorg Med Chem; 2016 Jun; 24(11):2361-2381. PubMed ID: 27112448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.
    Hejazi L; Rezaee E; Tabatabai SA
    Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents.
    Ahmed MF; Belal A
    Arch Pharm (Weinheim); 2015 Jul; 348(7):487-97. PubMed ID: 25921702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.